Login ¡¡ ¢· ¢¹ ¡¡ Mobile II
Hint Food ¸À°úÇâ Diet Health ºÒ·®Áö½Ä ÀÚ¿¬°úÇÐ My Book À¯Æ©ºê Frims ¿ø ·á Á¦ Ç° Update Site

¿ø·á ¡í ±â´É¼º ¡í ¹Ì³×¶ö

¸¶±×³×½· Mg Magnesium

¸¶±×³×½·
- ¸¶±×³×½· ¿ªÇÒ
- ¸¶±×³×½· Mg Èí¼ö ±âÀÛ
- MgCl2 ¿°È­¸¶±×³×½·, ÀÀ°íÁ¦
- °£¼ö(Á¶Á¦Çؼö¿°È­¸¶±×³×½·) : È£ÁÖ °£¼ö

¸¶±×³×½·Àº ¿±·Ï¼Ò(chlorophyll)ÀÇ ±¸¼º¼ººÐÀ̹ǷΠ³ì»ö¿±Ã¤¿¡ ¸¹ÀÌ ÇÔÀ¯µÇ¾î ÀÖÀ¸¸ç, °ß°ú·ù, µÎ·ù ¹× °î·ù ½ÄÇ°¿¡µµ dzºÎÇÏ´Ù. ±×·¯³ª °î·ù ÁßÀÇ ¸¶±×³×½·Àº µµÁ¤°úÁ¤ Áß 80~96%°¡ ¼Õ½ÇµÈ´Ù. µû¶ó¼­ ÀÏ»óÀûÀÎ ½Ä»ç¿¡¼­´Â ¸¶±×³×½·ÀÌ ÈçÈ÷ °áÇ̵ÇÁö´Â ¾ÊÀ¸³ª Á¤Á¦µÈ ½ÄÇ°À̳ª °¡°ø½ÄÇ°¿¡ÀÇ ÀÇÁ¸µµ°¡ ³ôÀº °æ¿ì ¸¶±×³×½· ¼·Ãë·®ÀÌ ³·¾ÆÁú ¼öµµ ÀÖ´Ù. ÀÌ¿Ü¿¡µµ ÀÌµé ½ÄÇ°ÀÇ ÃßÃâ¹° ¶Ç´Â ´ÙÀ½ÀÇ ÇÕ¼º¿ø·á¸¦ ÷°¡ÇÑ °¡°ø½ÄÇ°°ú ¸¶±×³×½· º¸Ãæ¿ë ½ÄÇ°µµ ÁÁÀº ±Þ¿ø½ÄÇ°ÀÌ´Ù

􀂃 ±Û·çÄܻ긶±×³×½·(magnesium gluconate)
􀂃 »êÈ­¸¶±×³×½·(magnesium oxide)
􀂃 ¼ö»êÈ­¸¶±×³×½·(magnesium hydroxide)
􀂃 ¿°È­¸¶±×³×½·(magnesium chloride)
􀂃 Ãʻ긶±×³×½·(magnesium acetate)
􀂃 ź»ê¸¶±×³×½·(magnesium carbonate)
􀂃 Ȳ»ê¸¶±×³×½·(magnesium sulphate)

±ÇÀå·®

¸¶±×³×½· Æò±ÕÇÊ¿ä·®Àº §¸ üÁß ´ç ÇÊ¿ä·®¿¡ Ç¥ÁØüÁßÀ» Àû¿ë½ÃÄÑ ±¸ÇÑ °ªÀÌ´Ù. ¿ì¸®³ª¶ó 20~29¼¼ ¼ºÀÎÀÇ °æ¿ì, ³²¼ºÀÇ Æò±ÕÇÊ¿ä·®Àº 285§·/ÀÏ, ¿©¼ºÀÇ Æò±ÕÇÊ¿ä·®Àº 235§·/ÀÏÀ̸ç, ±ÇÀå¼·Ãë·®Àº Æò±ÕÇÊ¿ä·®ÀÇ 120% ¼öÁØÀ¸·Î ³²¼ºÀÇ °æ¿ì 340§·/ÀÏ, ¿©¼ºÀÇ °æ¿ì 280§·/ÀÏÀÌ´Ù.
31¼¼ ÀÌ»ó ¼ºÀÎÀÇ °æ¿ì¿¡´Â ¿¬·É Áõ°¡¿¡ µû¸¥ ½ÄÀ̼¶À¯¼Ò ¼·Ãë Áõ°¡¿Í ½ÅÀå±â´É °¨¼Ò ¶§¹®¿¡ §¸ üÁß ´ç ÇÊ¿ä·®ÀÌ 20~29¼¼ ¼ºÀκ¸´Ù ³ô°Ô Ã¥Á¤µÇ¾î ³²¼ºÀÇ Æò±ÕÇÊ¿ä·®Àº 295§·/ÀÏ, ¿©¼ºÀÇ Æò±ÕÇÊ¿ä·®Àº 235§·/ÀÏÀ̸ç, ±ÇÀå¼·Ãë·®Àº Æò±ÕÇÊ¿ä·®ÀÇ 120% ¼öÁØÀ¸·Î ³²¼ºÀÇ °æ¿ì 350§·/ÀÏ, ¿©¼ºÀÇ °æ¿ì 280§·/ÀÏÀÌ´Ù.
50¼¼ ÀÌ»ó ¼ºÀΰú ³ëÀÎÀÇ °æ¿ì¿¡´Â Ç¥ÁØüÁßÀÌ ³·¾ÆÁü¿¡µµ ºÒ±¸ÇÏ°í °è¼ÓÀûÀÎ ½ÅÀå ±â´ÉÀÇ °¨¼Ò¸¦ °í·ÁÇÏ¿© 30~49¼¼ ¼ºÀÎÀÇ Æò±ÕÇÊ¿ä·® ¹× ±ÇÀå¼·Ãë·®ÀÌ Àû¿ëµÈ´Ù.
ÀӽźÎÀÇ °æ¿ì, ÀӽűⰣÀÇ Ã¼ÁßÁõ°¡´Â ÀϺΠ±ÙÀ°Á¶Á÷ Áõ°¡¿¡ ±âÀÎÇÏ°í ÀÌ´Â ¸¶±×³×½· ¿ä±¸·® Áõ°¡¸¦ ¼ö¹ÝÇϹǷΠÀûÀýÇÑ Ã¼ÁßÁõ°¡¿¡ ´ëÇÑ ¸¶±×³×½· Áõ°¡·®À» °è»êÇϸé Æò±ÕÇÊ¿ä·®ÀÌ 33§·/ÀÏ, ±ÇÀå¼·Ãë·®ÀÌ 40§·/ÀÏ·Î ÀÌ °ªÀ» ¼ºÀÎ ¿©¼ºÀÇ Æò±ÕÇÊ¿ä·®°ú ±ÇÀå¼·Ãë·®¿¡ °¢°¢ Ãß°¡ÇÑ´Ù. ¼öÀ¯ºÎÀÇ °æ¿ì¿¡´Â ¸¶±×³×½· ¼·Ãë·®ÀÌ ¸ðÀ¯ÀÇ ¸¶±×³×½· ÇÔ·®¿¡ ¿µÇâÀ» ÁÖÁö ¾Ê°í ¼Òº¯ Áß ¸¶±×³×½· ¹è¼³·®µµ °¨¼ÒÇϹǷΠºñ ÀӽŠ¿©¼º°ú µ¿ÀÏÇÑ Æò±ÕÇÊ¿ä·® ¹× ±ÇÀå¼·Ãë·®ÀÌ Àû¿ëµÈ´Ù.

Èí¼ö, ´ë»ç, ¹è¼³, ºÐÆ÷
¸¶±×³×½·ÀÇ Èí¼ö´Â ÁÖ·Î °øÀå°ú ȸÀå ºÎÀ§¿¡¼­ ´Ü¼ø È®»ê ¹× ´Éµ¿¼ö¼ÛÀÇ µÎ °¡Áö¿¡ ÀÇÇØ ÀϾ´Ù. ÀÏ»óÀûÀÎ ½ÄÀÌ¿¡¼­ÀÇ ¸¶±×³×½· Èí¼öÀ²Àº ¾à 40~60%ÀÌ¸ç ¸¶±×³×½·ÀÌ ºÎÁ·ÇÑ ½ÄÀ̸¦ ¼·ÃëÇÒ ¶§¿¡´Â Èí¼öÀ²ÀÌ 75% Á¤µµ±îÁö ³ô¾ÆÁö°í, ¸¶±×³×½·ÀÌ Ç³ºÎÇÑ ½ÄÀ̸¦ ¼·ÃëÇÒ ¶§¿¡´Â 25%Á¤µµ·Î ³·¾ÆÁø´Ù. ´Ù·®ÀÇ Ä®½· ¼·Ãë ½Ã¿¡´Â ¸¶±×³×½· Èí¼ö°¡ °¨¼ÒµÉ ¼ö ÀÖÀ¸¸ç, °î·ù ¿ÜÇÇ¿¡ ÀÖ´Â ÇÇƾ»êÀº ¸¶±×³×½·°ú ºÒ¿ë¼ºÀÇ ¿°À» Çü¼ºÇÏ¿© Èí¼öÀ²À» °¨¼Ò½ÃŲ´Ù. ¶ÇÇÑ ½ÄÀ̼¶À¯¼Ò°¡ ¸¹Àº ½Ä»ç¿¡¼­´Â ¸¶±×³×½·ÀÇ »ýüÀÌ¿ëÀ²ÀÌ ³·¾ÆÁú ¼ö ÀÖ´Ù. ¸¶±×³×½· Èí¼ö¸¦ ¾à°£ ³ôÀÏ ¼ö ÀÖ´Â ÀÎÀڷδ ºñŸ¹Î D¿Í 25(OH)D, 1,25(OH)2D µî ºñŸ¹Î DÀÇ ´ë»ç¹°µéÀÌ ÀÖ´Ù.
½ÅÀåÀº ü³»ÀÇ ¸¶±×³×½· ´ë»ç¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù. »ç¶÷¿¡¼­ Ç÷û ¸¶±×³×½·ÀÇ ¾à 75%´Â »ç±¸Ã¼¿¡¼­ ¿©°úµÇ´Âµ¥, ¿©°ú Àå¾Ö°¡ »ý±ä °æ¿ì¿¡´Â ½ÅÀåÀÇ ¼¼´¢°üÀ¸·Î À̵¿µÇ´Â ¸¶±×³×½·ÀÇ ¾çÀÌ °¨¼ÒÇÑ´Ù. Á¤»óÀûÀÎ °æ¿ì¿¡ ¸¶±×³×½·Àº ¼¼´¢°ü¿¡¼­ Àç Èí¼öµÇ¸ç, Àç Èí¼öµÇ´Â ¾çÀº ü³»¿¡ º¸À¯µÇ¾î ÀÖ´Â ¸¶±×³×½·ÀÇ ¾ç¿¡ ÀÇÇؼ­ Á¶ÀýµÇÁö¸¸, ½ÅÀåÀÇ »ç±¸Ã¼ ±â´ÉÀÌ ½ÉÇÏ°Ô ¼Õ»óµÇ¸é ¿ä¸¦ ÅëÇÑ ¸¶±×³×½·ÀÇ ¹è¼³ÀÌ °¨¼ÒµÇ¾î Ç÷û ³»ÀÇ ¸¶±×³×½··®ÀÌ Áõ°¡ÇÏ°Ô µÈ´Ù.
°Ç°­ÇÑ ¼ºÀÎÀÇ Ã¼³» ÃÑ ¸¶±×³×½· º¸À¯·®Àº ¾à 25g Á¤µµÀÌ´Ù. ÀÌÁß ¾à 50~60%ÀÇ ¸¶±×³×½·ÀÌ »À¿¡ Á¸ÀçÇϸç, ¾à 30%´Â ¼¼Æ÷³»¾×¿¡ ÇÔÀ¯µÇ¾î ÀÖ°í, ¾à 1% Á¤µµ°¡ ¼¼Æ÷¿Ü¾×¿¡ Á¸ÀçÇÑ´Ù. °ñ°Ý ¸¶±×³×½·ÀÇ 1/3Àº ¼¼Æ÷¿Ü¾×ÀÇ Á¤»óÀûÀÎ ¸¶±×³×½· ³óµµ¸¦ À¯ÁöÇÏ´Â ¸¶±×³×½· ÀúÀå°í·Î¼­ ÀÛ¿ëÇÑ´Ù. Ç÷û ¸¶±×³×½· ³óµµ´Â  .75~0.95mmol/L (1.8~2.3§·/100§¢)À̸ç, ¼¼Æ÷³»¾×ÀÇ ¸¶±×³×½· ³óµµ´Â 0.3~1.0mmol/L·Î ÀÏÁ¤ÇÏ°Ô À¯ÁöµÈ´Ù.
ü³» ¸¶±×³×½· Ç×»ó¼ºÀº ½ÅÀå¿¡ ÀÇÇØ ÁÖ·Î Á¶ÀýµÇ´Âµ¥ »ç±¸Ã¼¿¡¼­ ¿©°úµÈ ¸¶±×³×½·ÀÇ ´ëºÎºÐÀÌ ÀçÈí¼ö µÇ¹Ç·Î ³»Àμº ¸¶±×³×½·ÀÇ ¹è¼³·®Àº ±ØÈ÷ Àû´Ù.

<<¸¶±×³×½·ÀÇ ±â´É>>
½Åü ³» È¿¼Ò¹ÝÀÀ °ü¿©
300Á¾ ÀÌ»óÀÇ È¿¼Òü°è¿¡ ÀÖ¾î º¸Á¶ÀÎÀÚ(cofactor)·Î¼­ ÀÛ¿ëÇϸç, Çø±âÀû ¹× È£±âÀû ¿¡³ÊÁö »ý¼º°úÁ¤¿¡¼­ Mg-ATP º¹ÇÕüÀÇ ÀϺημ­ ¶Ç´Â Á÷Á¢ È¿¼Ò¸¦ È°¼ºÈ­½ÃÅ´À¸·Î½á ÀÛ¿ëÇÑ´Ù. ¶ÇÇÑ Áö¹æ, ´Ü¹éÁú ¹× ÇÙ»êÀÇ ÇÕ¼º, ±ÙÀ°ÀÇ ¼öÃà µî ü³»¿¡¼­ ÀϾ´Â »ýÈ­ÇÐÀû ȤÀº »ý¸®Àû °úÁ¤¿¡µµ ÇÊ¿äÇÏ´Ù. ÀÌ¿Ü¿¡µµ ¸¶±×³×½·Àº ½Å°æ ¹× ±ÙÀ°ÀÇ ¼¼Æ÷¸· ÀüÀ§ÀÇ À¯Áö¿Í ½Å°æ±Ù ¿¬Á¢ºÎ¿¡¼­ÀÇ Ãæ°ÝÀüµµ¿¡µµ ÇʼöÀûÀÎ ¿ªÇÒÀ» ÇÑ´Ù. ¸¶±×³×½·Àº ¶ÇÇÑ Na, K-ATPase È°¼º¿¡µµ ÇÊ¿äÇϸç, ½ÉÀå±ÙÀ°¼¼Æ÷ ³»¿¡¼­ ¼¼Æ÷¿Ü·Î Ä®·ýÀÌ ¿î¹ÝµÇ´Â °ÍÀ» Á¶ÀýÇÑ´Ù.

 
 

½Å°æÀڱذú ±ÙÀ° Á¶Àý
¸¶±×³×½·Àº Ä®½·, Æ÷Ÿ½·, ¼Òµð¿ò°ú ÇÔ²² ½Å°æÀÚ±ØÀü´Þ°ú ±ÙÀ°(½É±Ù, ³»Àå±Ù)ÀÇ ¼öÃà ¹× ÀÌ¿ÏÀÛ¿ëÀ» Á¶ÀýÇÏ´Â ³× °¡Áö ¾çÀÌ¿Â ÁßÀÇ Çϳª·Î, ¸¶±×³×½·°ú Ä®½·Àº ¼­·Î »ó¹ÝµÈ ÀÛ¿ëÀ» ÇÑ´Ù. Ä®½·Àº ½Å°æÀ» ÈïºÐ½ÃÅ°°í ±ÙÀ°À» ±äÀå½ÃÅ°´Â ¹Ý¸é, ¸¶±×³×½·Àº ½Å°æÀü´Þ ¹°ÁúÀÎ ¾Æ¼¼Æ¿Äݸ°ÀÇ ºÐºñ¸¦ °¨¼Ò½ÃÅ°°í ºÐÇظ¦ ÃËÁøÇÏ¿©, ½Å°æÀ» ¾ÈÁ¤½ÃÅ°°í ±ÙÀ°ÀÇ ±äÀåÀ» À̿ϽÃŲ´Ù. µû¶ó¼­ ¸¶±×³×½·Àº ¸¶ÃëÁ¦³ª Ç×°æ·ÃÁ¦ÀÇ ¼ººÐÀ¸·Î ÀÌ¿ëµÇ±âµµ ÇÑ´Ù.

<<±â´É¼º Ç¥½ÃÀÇ ¿¹>>
▪ ¸¶±×³×½·Àº ¿¡³ÊÁö ÀÌ¿ë¿¡ ÇÊ¿äÇÕ´Ï´Ù.
▪ ¸¶±×³×½·Àº ½Å°æ°ú ±ÙÀ°ÀÇ ±â´É À¯Áö¿¡ ÇÊ¿äÇÕ´Ï´Ù.

<<°áÇÌ>>
¸¶±×³×½·ÀÌ °áÇ̵Ǹé Ç÷Áß Ä®½· ³óµµ°¡ ³·¾ÆÁ® ÀúÄ®½·Ç÷Áõ(hypocalcemia)ÀÌ ³ªÅ¸³ª ±ÙÀ° °æ·Ã, °íÇ÷¾Ð, °ü»óÇ÷°ü°ú ³úÇ÷°üÀÇ °æ·ÃÀÌ ÀϾ ¼ö ÀÖ´Ù. ÀÌ´Â ³ªÆ®·ý°ú Ä®½· ÆßÇÁÀÇ ¼Õ»óÀ¸·Î ÀÎÇØ ½Å°æ¼¼Æ÷ ±â´ÉÀÌ ºñÁ¤»óÀûÀ¸·Î µÇ±â ¶§¹®¿¡ ³ªÅ¸³­´Ù. ¶ÇÇÑ ¸¶±×³×½·Àº °ñ°Ý°ú ¹«±âÁúÀÇ Ç׻󼺿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ¸ç °ñ°Ý¼¼Æ÷ÀÇ ±â´É»Ó¸¸ ¾Æ´Ï¶ó »ÀÀÇ ¼ö»êÈ­ÀÎȸ¼® (hydroxyapatite) °áÁ¤ÀÇ Çü¼º°ú ¼ºÀå¿¡ Á÷Á¢ÀûÀÎ ¿µÇâÀ» Áֱ⠶§¹®¿¡, ¸¶±×³×½· °áÇÌÀº Æó°æ ÈÄ °ñ´Ù°øÁõ ¹ß»ýÀÇ ¿äÀÎÀÌ µÉ ¼öµµ ÀÖ´Ù.
ÇÑÆí ³ëÀÎÀº ½Ä¿åºÎÁø, Ä¡¾Æ ¹®Á¦, ºÎ½ÇÇÑ ½Ä»ç µîÀ¸·Î ÀÎÇØ ¸¶±×³×½· ¼·Ãë°¡ ³·Àº ÆíÀÌ¸ç ¶ÇÇÑ Èí¼öÀ²µµ °¨¼ÒµÇ¾î ¸¶±×³×½· °áÇÌÀÌ ÀϾ±â ½¬¿ì¹Ç·Î ÁÖÀÇÇØ¾ß ÇÑ´Ù. ÀÌ ¹Û¿¡µµ ÀÌ´¢Á¦ »ç¿ëÀÚ, ¾ËÄÚ¿Ã Áßµ¶ÀÚ, ´ç´¢º´À̳ª ´õ¿î ±âÈÄ¿¡¼­ ¸î ÁÖ°£ ½ÉÇÏ°Ô ¶¡À» È긮°Å³ª Àå±â°£ÀÇ ¼³»ç³ª ±¸Åä½Ã °áÇÌµÉ ¼ö ÀÖ´Ù.

<<µ¶¼º>>
½ÄÇ° Áß¿¡ °íÀ¯·Î ÇÔÀ¯µÇ°Å³ª °­È­µÈ ¸¶±×³×½·Àº À¯ÇØ¿µÇâÀ» º¸ÀÌÁö ¾ÊÀ¸¹Ç·Î ¸¶±×³×½· ÀÇ »óÇѼ·Ãë·®Àº ½ÄÇ° ¿Ü(ÁÖ·Î ÇÏÁ¦ µî ¾à¸®Àû ¸ñÀû)±Þ¿ø ¼·Ãë·®¿¡ ±¹ÇÑÇÑ´Ù. µ¶¼ºÁ¾¸»Á¡ Àº »ïÅõ¼º ¼³»çÀ̸ç, ½ÅÀå±â´ÉÀå¾Ö°¡ ÀÖÀ» °æ¿ì °í¸¶±×³×½·Ç÷Áõ(>2.5~3.5mmol/L)À» À¯¹ßÇÒ ¼ö ÀÖ´Ù

Hypermagnesemia is an electrolyte disturbance in which there is an abnormally elevated level of magnesium in the blood.[1] Usually this results in excess of magnesium in the body.
Hypermagnesemia occurs rarely because the kidney is very effective in excreting excess magnesium. It usually develops only in people with renal failure who are given magnesium salts or who take drugs that contain magnesium (e.g. some antacids and laxatives).[2] It is usually concurrent with hypocalcemia and/or hyperkalemia.

- Weakness, nausea and vomiting
- Impaired breathing
- Decreased respirations
- Hypotension
- Hypocalcemia
- Arrhythmia and Asystole
- Decreased or absent deep tendon reflexes
- Bradycardia
- dizziness
- sleepyness
- Arrhythmia and asystole are possible cardiac complications of hypermagnesemia. Magnesium acts as physiologic calcium blocker, which results in electrical conduction abnormalities.

Clinical consequences related to serum concentration:

4.0 mEq/l hyporeflexia
>5.0 mEq/l Prolonged atrioventricular conduction
>10.0 mEq/l Complete heart block
>13.0 mEq/l Cardiac arrest
Note that the therapeutic range for the prevention of the pre-eclampsic uterine contractions is: 4.0-7.0 mEq/L.[3] As per Lu and Nightingale,[4] serum Mg2+ concentrations associated with maternal toxicity (also neonate depression - hypotonia and low Apgar scores) are:

7.0-10.0 mEq/L - loss of patellar reflex
10.0-13.0 mEq/L - respiratory depression
15.0-25.0 mEq/L - altered atrioventricular conduction and (further) complete heart block
>25.0 mEq/L - cardiac arrest


µÎÀ¯ÀÇ ´Ü¹éÁúÀ» ÀÀ°í½Ãų ¶§ ÇÊ¿äÇÑ °ÍÀº ¿­ÀÌ´Ù. Àú¿Â¿¡¼­´Â Ä£¼ö¼ºÀ̶ó Á¡µµ°¡ ³ôÀº Á×󷳵ǵµ ´Ü¹éÁú »ç½½°£¿¡ ³×Æ®¿öÅ©°¡ Çü¼ºµÇÁö ¾Ê¾Æ µÎºÎ°¡ µÇÁö ¾Ê´Â´Ù. ¿Âµµ°¡ 70µµ°¡ ³Ñ¾î°¡¸é µÎºÎ´Ü¹éÁúÀº ¼Ò¼ö¼ºÀ¸·Î º¯ÇÏ¸ç ´Ü¹éÁúÀ» °¨½Î´Â ¹°ÃþÀÌ °¨¼ÒÇÏ¿© ´Ü¹éÁú »ç½½ÀÌ ¾ûÅ°±â ÁÁ¾ÆÁø´Ù. À̶§ Ä®½·À̳ª ¸¶±×³×½·°°Àº 2°¡ ÀÌ¿ÂÀÌ ÀÖÀ¸¸é ¾ûÅ°¾î µÎºÎ°¡ µÈ´Ù
±×·±µ¥ Ä®½·º¸´Ù ¸¶±×³×½·ÀÌ ÈξÀ °áÇÕÇÏ´Â ¼Óµµ°¡ »¡¶ó¼­ Á¶ÀýÀÌ ½±Áö ¾Ê´Ù. Ä®½·Àº ¼­¼­È÷ ¾ÈÁ¤µÇ°í ±ÕÀÏÇÏ°Ô ÀÀ°í°¡ ÀϾ¼­ µÎºÎÀÇ Ç°Áú°ú ¼öÀ²ÀÌ ÁÁÁö¸¸ ¸¶±×³×½·Àº ¹ÝÀÀÀÌ ³Ê¹« »¡¶ó ºÎºÐÀûÀ¸·Î ÀÀ°í°¡ ÀϾ ¼öÀ²ÀÌ ¶³¾îÁø´Ù.
±×·±µ¥ ÃÖÁ¾ µÎºÎÀÇ ¸ÀÀº ¸¶±×³×½·À¸·Î ÀÀ°í½ÃŲ °ÍÀÌ ÈξÀ ÁÁ´Ù. ±×·¡¼­ ´ë±â¾÷Àº ¿Â°® ±â¼ú°ú ¹æ¹ýÀ» È°¿ëÇÏ¿© ¹«Á¶°Ç »ç¿ëÀÌ ¸¶±×³×½·À¸·Î ÀÀ°í¸¦ ½ÃŲ´Ù.
±×·±µ¥ ÀÌ·¸°Ô ´Ü¹éÁú°ú ¹ÝÀÀ¼ºÀÌ ³ôÀº ¸¶±×³×½·ÀÌ ¼¼Æ÷¾ÈÀ» ä¿ì°í ÀÖ´Ù. ¹ÝÀÀ¼ºÀÌ ´À¸° Ä®½·Àº ¼¼Æ÷¹Û¿¡ ÀÖ°í ¼¼Æ÷¾È¿¡´Â °ÅÀÇ ¾ø´Âµ¥, ¸¶±×³×½·Àº ¼¼Æ÷¹Û¿¡´Â º°·Î ¾ø°í, ¼¼Æ÷ ¾È¿¡´Â Á¤¸» ¸¹´Ù.
1°¡ ¾çÀ̿¿¡¼­´Â ³ªÆ®·ýµµ ¼¼Æ÷¹Û¿¡´Â ¸¹Áö¸¸ ¼¼Æ÷¾È¿¡´Â º°·Î ¾ø°í, Ä®·ýÀº ¹Ý´ë·Î ¼¼Æ÷¹Û¿¡´Â º°·Î ¾ø°í, ¼¼Æ÷ ¾È¿¡´Â ¸¹´Ù.

 



 

 

ÀÌ¿ÂÀº ÀÛÁö¸¸ 6¼öÈ­¹°·Î ä³Î Åë°ú°¡ Èûµé´Ù
 


ÆäÀ̽ººÏ       ¹æ¸í·Ï      ¼öÁ¤ 2019-06-06 / µî·Ï 2010-09-20 / Á¶È¸ : 15851 (697)



¿ì¸®ÀÇ °Ç°­À» ÇØÄ¡´Â ºÒ·®Áö½ÄÀÌ ¾ø´Â ¾Æ¸§´Ù¿î ¼¼»óÀ» ²Þ²Ù¸ç ...  2009.12  ÃÖ³«¾ð


¡¡